New discovery remarkably improves immunotherapy in bladder cancer and beyond
BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated the muscle layer—is one of the earliest forms of cancer immunotherapy. Now, 50 years after it was first developed from the tuber…